Tidal Model-Based ACT for Depression
TIDAL-ACT
THE EFFECT OF ACCEPTANCE AND STABİLİTY BASED PSYCHOEDUCATİON ON MEANİNG OF LİFE AND CONSCİOUS SELF-CARE İN PATİENTS WİTH DEPRESSİON BASED ON TİDAL MODEL
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose of this randomized controlled clinical trial is to evaluate the effectiveness of an Acceptance and Commitment Therapy (ACT)-oriented psychoeducation program based on the Tidal Model in patients diagnosed with depression who are receiving transcranial magnetic stimulation (TMS) treatment at a university hospital psychiatry clinic. The primary objective of this study is to determine whether participation in the psychoeducation program improves meaning in life and conscious self-care compared to usual treatment alone. The main questions this study aims to answer are:
- Does the ACT-oriented psychoeducation program increase participants' level of meaning in life?
- Does the program improve conscious self-care behaviors in individuals with depression? Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive an 8-week structured psychoeducation program in addition to standard TMS treatment. The control group will continue to receive standard treatment without additional psychoeducation. Participants in the intervention group will attend weekly psychoeducation sessions focusing on psychological flexibility, values clarification, coping strategies, and self-care practices. Outcome measures will be collected at baseline, immediately after the intervention, and one month after completion of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2026
CompletedStudy Start
First participant enrolled
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMarch 2, 2026
February 1, 2026
2 months
February 24, 2026
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Meaning in Life
Measured using the Meaning in Life Questionnaire (MLQ) to assess changes in participants' perceived meaning and purpose in life.
Baseline (pre-intervention) to immediately post-intervention (8 weeks), and 1-month follow-up
Study Arms (2)
Control group receiving standard treatment (n=23)
NO INTERVENTIONParticipants receive standard Transcranial Magnetic Stimulation (TMS) treatment only, without additional psychoeducation or behavioral intervention.
Experimental group receiving ACT based on Tidal Model (n=23)
EXPERIMENTALParticipants in the experimental group receive 8-session Acceptance and Commitment Therapy (ACT)-based psychoeducation, structured within the Tidal Model, in addition to standard Transcranial Magnetic Stimulation (TMS) treatment. The program is designed to enhance meaning in life and conscious self-care. Total participants: 23.
Interventions
This intervention combines standard Transcranial Magnetic Stimulation (TMS) treatment with an 8-session Acceptance and Commitment Therapy (ACT)-based psychoeducation program structured specifically within the Tidal Model framework. Unlike standard ACT or TMS interventions alone, this program integrates mindfulness, value-based actions, and experiential exercises tailored for patients with depression receiving TMS, aiming to enhance meaning in life and conscious self-care.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Receiving treatment for depression for at least 6 months
- Within the 6-month period following TMS treatment
- Able to communicate in Turkish without difficulty
- No hearing problems, cognitive impairments, or additional psychiatric disorders
- Willing to participate and has provided written informed consent
You may not qualify if:
- Participant withdraws voluntarily from the study
- Relapse of depression during the study period requiring psychiatric hospitalization
- Sİtuation in which participants do not attend two consecutive sessions
- Starting participants on other psychotropic medications (e.g., ANTIPSYCHOTIC, MOOD STABILIZER, etc.) IN ADDITION TO THEIR ongoing antidepressant or anxiolytic treatments, and additional psychotherapies other than the ACT intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gazi University Health Research and Application Center, Gazi Hospital
Ankara, 06790, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ebru Akgün Çıtak, Professor
Baskent University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 2, 2026
Study Start
February 26, 2026
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared to protect participant privacy and confidentiality. Only aggregated, anonymized results will be published.